Get the lashes you've always dreamed of
LATISSE™ is a prescription eyelash growth treatment applied at home, before bed to the base of the upper eyelid margin once- a-day with a sterile, single-use-per-eye disposable applicator brush.1
LATISSE™ contains the same active ingredient and is the same formulation as LUMIGAN® (bimatoprost ophthalmic solution 0.03%), which has been approved in Canada since 2002 as a treatment to lower intraocular pressure in people with open-angle glaucoma or ocular hypertension. During the clinical development program for LUMIGAN®, patients reported experiencing growth of longer, thicker and darker lashes.
The safety of LUMIGAN® has been well-established in 32 clinical trials involving more than 5,700 glaucoma patients. It also has more than 13 years of clinical trial experience, with 65 million bottles distributed worldwide to-date.
In a clinical trial, treatment with LATISSE™ was well tolerated. In one multi-centre, double-masked, randomized, vehicle-controlled, parallel study of four months duration, most adverse events detected were ocular, mild to moderate, and not serious.
The most frequently reported adverse events with the use of LATISSE™ (bimatoprost topical solution 0.03% w/v) were eye pruritus (itchy eyes), conjunctival hyperaemia (eye redness), skin hyperpigmentation, ocular irritation, dry eye symptoms, and erythema (redness) of the eyelid. Each of these events occurred in less than 4 per cent of patients.1
LATISSE™ may cause darkening of the eyelid skin, which may be reversible. Although not reported in clinical studies, LATISSE™ may cause increased brown iris pigmentation, which could be permanent.1 In LUMIGAN® studies, iris pigmentation change was a reported effect in 1.5 per cent of patients receiving once-daily dosing.6
Although the precise mechanism of action is not entirely understood, the growth of eyelashes is believed to occur by increasing the duration of the anagen or growth phase of the hair cycle. Increased thickness and fullness is believed to result from extending the anagen phase and the increase in darkness occurs by the stimulation of pigment (melanin) formation in the hair follicles. The overall effect is increased length, thickness and darkness of eyelashes (prominence). 1
Once treatment with LATISSE™ is discontinued, over a period of several weeks to months (average eyelash hair cycle), eyelash prominence will return to pre-treatment levels. Therefore, to keep lashes looking luscious and beautiful, continued treatment with LATISSE™ is necessary
LATISSE (bimatoprost topical solution 0.03%) is a prescription medication. A physcian consultation prior to the intial prescription will be necessary.
